Koligo Therapeutics Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$14.5M
- Investors
-
1
Koligo Therapeutics General Information
Description
Koligo Therapeutics Ltd is a biotechnology company based in Australia. It is focused on treating chronic pancreatitis, Type 1 Diabetes and Other Pancreatic diseases. The company has developed Kyslecel which is used in the treatment of patients suffering from chronic or acuterecurrent pancreatitis, a debilitating and painful condition with less treatment options.
Contact Information
Website
www.koligo.netCorporate Office
- 204 South Floyd Street
- Louisville, KY
- United States
Corporate Office
- 204 South Floyd Street
- Louisville, KY
- United States
Koligo Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 15-Oct-2020 | $14.5M | Completed | Generating Revenue | ||
| 3. IPO | 11-Apr-2019 | Completed | Generating Revenue | |||
| 2. Mezzanine | 07-Mar-2018 | $2M | $2M | Completed | Generating Revenue | |
| 1. Angel (individual) | 13-Dec-2017 | $5K | $5K | Completed | Startup |
Koligo Therapeutics Patents
Koligo Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2018452704-A1 | Cell separation apparatus and methods of use | Inactive | 13-Dec-2018 | ||
| EP-3893949-A1 | Cell separation apparatus and methods of use | Inactive | 13-Dec-2018 | ||
| EP-3893949-A4 | Cell separation apparatus and methods of use | Inactive | 13-Dec-2018 | ||
| US-20110218396-A1 | Methods and compositions to support tissue integration and inosculation of transplanted tissue and transplanted engineered penile tissue with adipose stromal cells | Active | 05-Mar-2010 | ||
| US-8727965-B2 | Methods and compositions to support tissue integration and inosculation of transplanted tissue and transplanted engineered penile tissue with adipose stromal cells | Active | 05-Mar-2010 | A61F2/26 |
Koligo Therapeutics FAQs
-
When was Koligo Therapeutics founded?
Koligo Therapeutics was founded in 2016.
-
Where is Koligo Therapeutics headquartered?
Koligo Therapeutics is headquartered in Louisville, KY.
-
What industry is Koligo Therapeutics in?
Koligo Therapeutics’s primary industry is Laboratory Services (Healthcare).
-
Is Koligo Therapeutics a private or public company?
Koligo Therapeutics is a Private company.
-
What is the current valuation of Koligo Therapeutics?
The current valuation of Koligo Therapeutics is .
-
What is Koligo Therapeutics’s current revenue?
The current revenue for Koligo Therapeutics is .
-
How much funding has Koligo Therapeutics raised over time?
Koligo Therapeutics has raised $6.26M.
-
When was Koligo Therapeutics acquired?
Koligo Therapeutics was acquired on 15-Oct-2020.
-
Who acquired Koligo Therapeutics?
Koligo Therapeutics was acquired by Orgenesis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process